T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$2.31B |
| 2 |
Apple
AAPL
|
+$1.58B |
| 3 |
Sherwin-Williams
SHW
|
+$1.37B |
| 4 |
HubSpot
HUBS
|
+$1.32B |
| 5 |
Kenvue
KVUE
|
+$1.25B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.37B |
| 2 |
Lam Research
LRCX
|
+$1.54B |
| 3 |
Applied Materials
AMAT
|
+$1.33B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.19B |
| 5 |
Halliburton
HAL
|
+$1.16B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.32% |
| 2 | Healthcare | 15.15% |
| 3 | Financials | 10.54% |
| 4 | Consumer Discretionary | 10.48% |
| 5 | Communication Services | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Yum China
YUMC
$16.4B
| $503M | 0.06% |
11,181,919
-3,282,342
| -23% | -$109M |
|
277
Western Alliance Bancorporation
WAL
$9.01B
| $503M | 0.06% |
5,813,951
+701,732
| +14% | +$54M |
|
|
BPMC
278
DELISTED
Blueprint Medicines
BPMC
| $498M | 0.06% |
5,387,267
-486,125
| -8% | -$48.3M |
|
279
monday.com
MNDY
$3.63B
| $496M | 0.06% |
1,784,393
-549,839
| -24% | -$136M |
|
280
Conagra Brands
CAG
$7.18B
| $491M | 0.06% |
15,100,175
-1,825,950
| -11% | -$56M |
|
|
RNAM
281
DELISTED
Avidity Biosciences
RNAM
| $488M | 0.06% |
10,633,962
-282,664
| -3% | -$12.3M |
|
282
PTC
PTC
$16.1B
| $486M | 0.06% |
2,689,336
+2,154,655
| +403% | +$379M |
|
283
CrowdStrike
CRWD
$226B
| $486M | 0.06% |
6,928,688
-1,688,408
| -20% | -$120M |
|
284
Franco-Nevada
FNV
$45.5B
| $483M | 0.06% |
3,886,277
+1,242,243
| +47% | +$154M |
|
285
Canadian National Railway
CNI
$76.4B
| $481M | 0.06% |
4,109,320
+105,715
| +3% | +$12.3M |
|
286
Ferguson
FERG
$47.4B
| $477M | 0.05% |
2,401,254
+638,759
| +36% | +$129M |
|
287
Trane Technologies
TT
$105B
| $468M | 0.05% |
1,202,965
-611,572
| -34% | -$212M |
|
288
Blackrock
BLK
$180B
| $467M | 0.05% |
492,178
+94,294
| +24% | +$81.6M |
|
289
Shell
SHEL
$249B
| $467M | 0.05% |
7,084,623
+495,554
| +8% | +$35.1M |
|
290
MKS Inc
MKSI
$20.7B
| $465M | 0.05% |
4,278,634
-2,566,927
| -37% | -$305M |
|
291
Abbott
ABT
$192B
| $462M | 0.05% |
4,050,501
-11,974
| -0.3% | -$1.31M |
|
292
Copart
CPRT
$26.8B
| $460M | 0.05% |
8,773,793
+456,370
| +5% | +$23.7M |
|
293
Martin Marietta Materials
MLM
$32.7B
| $451M | 0.05% |
837,098
-394,352
| -32% | -$213M |
|
294
Viper Energy
VNOM
$15.2B
| $448M | 0.05% |
9,938,978
+9,884,220
| +18,051% | +$435M |
|
295
Zebra Technologies
ZBRA
$17.9B
| $448M | 0.05% |
1,209,646
-240,200
| -17% | -$80.7M |
|
296
Enbridge
ENB
$112B
| $446M | 0.05% |
10,993,277
-557,315
| -5% | -$21.5M |
|
297
Ball Corp
BALL
$16.4B
| $439M | 0.05% |
6,465,706
+109,844
| +2% | +$6.97M |
|
298
Marvell Technology
MRVL
$195B
| $437M | 0.05% |
6,062,082
+5,415,578
| +838% | +$374M |
|
299
The Mosaic Company
MOS
$7.18B
| $437M | 0.05% |
16,311,725
+1,985,132
| +14% | +$54.6M |
|
300
APi Group
APG
$18.8B
| $430M | 0.05% |
19,537,029
-2,572,227
| -12% | -$60.4M |
|
Similar funds
T. Rowe Price Associates's Q3 2024 Portfolio in Review
As of Q3 2024, T. Rowe Price Associates held 3,059 positions worth $869B, up 3.9% from $836B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Trading was light in Q3 2024: portfolio turnover was 4.3%. T. Rowe Price Associates opened 82 new positions and exited 51, leaving the 3,059-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 34% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q3 2024 buy was Lineage Inc: 4,699,854 shares worth $368M.
- T. Rowe Price Associates added most to Advanced Micro Devices in Q3 2024, an estimated $2.31B increase.
- T. Rowe Price Associates's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $4.37B.
- T. Rowe Price Associates fully exited Morphic Holding, Inc. Common Stock in Q3 2024, selling an estimated $75.2M.
- T. Rowe Price Associates's ten largest holdings make up 34% of its $869B portfolio in Q3 2024.
- T. Rowe Price Associates opened 82 new positions and closed 51 in Q3 2024.
- T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $869B.
Based on T. Rowe Price Associates's 13F filing for Q3 2024, filed 14 Nov 2024.